Oral testosterone must be methylated as part of hormone therapy for women with reduced sexual desire, and may have negative metabolic effects compared with transdermal bioidentical testosterone.
Within a year, the FDA had put a “black box” warning on estrogen products used in hormone therapy—the most serious warning the agency places on prescription drugs—about the risk of ...